AUM Increases to HK$157.0 billion, Hitting Historical High China Everbright Limited (“Everbright” or “the Group”, stock code: 165.HK) today announced…
Browsing: Business
SMEs advised to diversify into northern Vietnam, Greater Bay Area The confidence level of Hong Kong’s exporters has fallen to…
专注于研发治疗免疫疾病,病毒性疾病和多种癌症疗法的免疫药物公司AIM ImmunoTech(纽约证券交易所股票代码:AIM)今天宣布,日本国立传染病研究所(NIID)将 开始测试AIM的药物安普利近(Ampligen),以作为SAV-CoV-2引起的新型冠状病毒感染性疾病——新型冠状病毒肺炎的潜在治疗药物。 实验项目将在NIID和东京大学进行。 测试和研究工作目前正在由NIID流感病毒研究中心主任、东京世界卫生组织(WHO)流感参考和研究合作中心主任Hideki Hasegawa(医学博士、科学博士),和NIID病理学系、东京理工大学生物科学与技术系Ishiohe Takeshi(科学博士)共同主持进行。 “正如我们一直所说的,这种新出现的大规模流行病是由一种病毒引起的,这种病毒的调节RNA序列与原始的SARS冠状病毒(SARS-CoV-1)在发病机制上几乎相同。这意味着先前在SARS-CoV-1动物实验中对安普利近的研究预示着它对新病毒可能会起到类似保护作用。世界卫生组织最近将这种新出现的高致病性病毒更名为SARS-CoV-2。”AIM首席执行官Thomas K. Equels表示。“在美国国立卫生研究院的动物实验中,安普利近对早前的SARS冠状病毒表现出优异的抗病毒活性。在对感染了SARS的小鼠的研究中,安普利近是唯一一种被证明具有显著存活效应的药物:接受安普利近治疗的小鼠存活率达到100%,而未接受治疗的小鼠则无一存活。鉴于SARS-CoV-2与SARS-CoV-1有许多关键的相似之处,在目前尚无针对这种高致病性冠状病毒的有效疗法的情况下,安普利近可能在研发保护性早发疗法中起到关键作用。我们很自豪能与日本备受尊敬的NIID合作,共同抗击这一潜在的流行病。” 安普利近作为一种广谱抗病毒药物具有非常完善的安全性(请参阅:https://aimimmuno.com/events-presentations/ “ 安普利近作为一种抗病毒药物”,安全幻灯片7-15)。 AIM将向股东和市场及时披露最新成果。 参考美国国立卫生研究院(NIH)签订的安普利近治疗SARS的研究: – Day 2009: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2787736/ – Barnard 2006: https://journals.sagepub.com/doi/abs/10.1177/095632020601700505…
Share offer of 375,000,000 ordinary shares at between HK$0.335 and HK$0.380 per share expected to raise net proceeds of approximately…
Sheng Ye Capital Limited (“Sheng Ye Capital” or the “Group”; Stock code: 6069), a fintech-driven supply chain financial services provider…
Business Transformation Successes; Three Categories of Business Continue to Capture Growth NOVA Group Holdings Limited (the “Group”; stock code: 1360),…
SHELTON, CT / ACCESSWIRE – (ACN Newswire) – NanoViricides, Inc. (NYSE American: NNVC), a global leader in the development of…
The Hong Kong Institute of Directors (HKIoD) calls on listed company directors to faithfully discharge their duty as they tackle…
Far Eastern Bank, which marks 30 years of successful financial activity this year, became the fourth bank in Russia to…
Cedar Holdings Group Co Ltd (“Cedar Holdings”), China’s leading supplier of bulk commodities, and Stemcor Global Holdings Ltd (“Stemcor”), a…
Southeast Asian luxury online fashion marketplace BlinQ today announced a commercial affiliation with the leading global online fashion retailer that…
EXX Africa publishes a special report on Angola shadow state executives who imperil the country’s privatisation process. Using a high-profile…
Tonghai Financial is pleased to announce that China Tonghai Capital was presented with the Best Privatization at the The Asset…
Tonghai Financial is pleased to announce that China Tonghai Capital was presented with the Best Privatization at the The Asset…
Kwan Yong Holdings Limited (“Kwan Yong” or the “Group”), a main contractor in the provision of building construction works in…
At present, AVIC International Holdings Limited (“AVIC IHL” or the “Company”, stock code on the Hong Kong Stock Exchange: 00161)…
Tonghai Financial is Honoured with “Corporate Governance – The Listed Enterprise Excellence Awards 2019” by Capital Weekly In Recognition of…
Singapore-listed Alliance Healthcare Group Limited, an integrated healthcare firm that leverages technology to provide broad suite of healthcare services primarily…
Publicly listed firm Century Properties Group, Inc. has made significant achievements this year with 2,853 condominium unit completions and bullish…
Following the successful acquisition of Chaucer in late 2018, good news came in again for China Re Group at the…